longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

"Africa's King of Mobile Phones" TRANSSION is set to go public in Hong Kong as early as September, raising HKD 3.9 billion

Stheadline
Aug 8, 2026 at 01:46 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

TRANSSION is expected to go public in Hong Kong as early as September, aiming to raise approximately USD 500 million (HKD 3.9 billion), with CITIC Securities Co., Ltd. as the sole sponsor. BIOKIN Pharmaceuticals has restarted its Hong Kong IPO, expecting to raise USD 600-800 million, with co-sponsors including CITIC Securities Co., Ltd. NASN TECH's first-day listing rose by 64.1%, with a profit of HKD 668 per lot

The news about new stocks in Hong Kong continues to pour in. According to foreign media reports, TRANSSION Holdings, known as the "King of African Mobile Phones," which has already been listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board, plans to complete its listing in Hong Kong as early as September, raising approximately USD 500 million, equivalent to HKD 3.9 billion. TRANSSION Holdings closed yesterday at RMB 5.703 billion, down 0.4%, with a market capitalization of approximately RMB 65.652 billion.

TRANSSION Holdings received a filing notice from the China Securities Regulatory Commission this Thursday, planning to issue no more than 132 million overseas listed ordinary shares and list on the Hong Kong Stock Exchange. CITIC Securities Co., Ltd. is its sole sponsor.

BIOKIN Restarts Listing Plan

Sichuan BIOKIN, which halted its IPO last November, has restarted its Hong Kong listing plan and resubmitted its listing application to the Hong Kong Stock Exchange this Thursday (6th). According to the latest reports from foreign media, the fundraising amount for this listing by Sichuan BIOKIN may be around USD 600 million to USD 800 million, equivalent to HKD 4.7 billion to HKD 6.2 billion.

According to its prospectus, CITIC Securities Co., Ltd., Jefferies, China International Capital Corporation, and Deutsche Bank are its joint sponsors. The company's A shares closed at RMB 307.07, up 1.7%, with a market capitalization exceeding RMB 126.7 billion. The company decided to postpone its listing plan last November, considering the current market conditions, at that time aiming to raise a maximum of HKD 3.36 billion.

NASN TECH Debuts with a 64% Gain, Earning HKD 668 per Lot

Additionally, the newly listed stock NASN TECH (2261) continued its strong performance in the gray market yesterday, closing at HKD 17.1, up 64.1% from the offering price of HKD 10.42, earning HKD 668 per lot before fees

Login to unlock1,437characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

  • Mar 30, 2026 at 11:02 PMFive Financial Institutions' Chief Economists Discuss Economic Trends: China's Q1 GDP Growth Expected to Reach Around 5%
  • Mar 26, 2026 at 12:51 PMMaking a Fortune Silently: 27.6 Billion! CITIC Securities Co., Ltd.'s "Proprietary Printing Press" Roars, "Mysterious Bu…
  • Jan 14, 2026 at 12:11 PMAfter 3 years, CITIC Securities' growth rate has finally returned to double digits
  • Jan 14, 2026 at 12:03 PM"Brokerage King" CITIC Securities: Net profit will exceed 30 billion by 2025
  • Jan 4, 2026 at 11:37 PMChief Economist Outlook 2026: Coordinated Efforts of Fiscal and Monetary Policies to Sustain Economic Recovery

Related Stocks

BIOKIN

BIOKIN

HK02615

NASN TECH

NASN TECH

HK02261

+0.06%

TRANSSION

TRANSSION

SH688036

-0.15%

LongbridgeAI